Skip to main content
Earnings Labs
Monopar Therapeutics Inc. logo

Monopar Therapeutics Inc. (MNPR)

NASDAQ·Healthcare·Biotechnology

$118.99

+6.58%

Mkt Cap $725.84M

Analyst Ratings

Buy

5

Hold

0

Sell

0

Price Target (19 analysts)

$118.00

Range $105.00$125.00

Implied Upside

-0.8%

Consensus $118.00 vs current $118.99